Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC39640GPLGIAGQ TFA纯度: >99.50% / >98.00%
GPLGIAGQ TFA 是一种 MMP2 可切割的多肽,在脂质体和胶束纳米载体中都被用作刺激敏感的连接物,用于 MMP2 触发的肿瘤靶向治疗。GPLGIAGQ TFA可用于合成光动力治疗 (PDT) 中独特的 MMP2 靶向光敏剂。
- GC39699Aurintricarboxylic acidCAS: 4431-00-9
A protein synthesis inhibitor with diverse biological activities
- GC39798ScoulerineCAS: 6451-73-6纯度: >99.00%
A benzylisoquinoline alkaloid with diverse biological activities
- GC39808DidesmethylrocaglamideCAS: 177262-30-5纯度: >98.00%
Didesmethylrocaglamide 是一种 Rocaglamide 的衍生物,也是一种有效的真核起始因子 4A (eIF4A) 抑制剂。Didesmethylrocaglamide 具有有效的生长抑制活性,IC50 为 5 nM。Didesmethylrocaglamide 抑制多种促进生长的信号通路,并诱导肿瘤细胞凋亡 (apoptosis)。抗肿瘤活性。
- GC39814MitoguazoneCAS: 459-86-9纯度: >98.00%
Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) 是一种具有有效抗肿瘤活性的合成多羰基衍生物。Mitoguazone 是一种可透过血脑屏障的竞争性的 S-腺苷-蛋氨酸脱羧酶 (S-adenosyl-methionine decarboxylase) 抑制剂,可破坏多胺的生物合成。Mitoguazone 诱导细胞凋亡 (apoptosis),可抑制 HIV DNA 整合到单核细胞和巨噬细胞中的细胞 DNA 中。Mitoguazone 具可用于急性白血病,霍奇金淋巴瘤和非霍奇金淋巴瘤的研究。
- GC39815Semapimod tetrahydrochlorideCAS: 164301-51-3纯度: >98.00%
Semapimod tetrahydrochloride (CNI-1493) 是促炎细胞因子产生 (proinflammatory cytokine) 的抑制剂,可抑制TNF-α、IL-1β 和 IL-6。Semapimod tetrahydrochloride 抑制巨噬细胞 p38 MAPK 和一氧化氮生成。Semapimod tetrahydrochloride 抑制 TLR4 信号 (IC50≈0.3 μM)。Semapimod tetrahydrochloride 在多种炎症和自身免疫性疾病中具有潜在的作用。
- GC40007Malformin ACAS: 3022-92-2纯度: >95.00%
A cyclopentapeptide fungal metabolite with diverse biological activities
- GC40065Meloxicam-d3CAS: 942047-63-4纯度: >99.00%
An internal standard for the quantification of meloxicam
- GC40085Pazopanib-d6CAS: 1219592-01-4纯度: >99.00%
An internal standard for the quantification of pazopanib
- GC40094all-trans Retinoic Acid-d5纯度: >99.00%
An internal standard for the quantification of all-trans retinoic acid
- GC40118Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)纯度: >95.00%
An inhibitor of caspase-8 and granzyme B
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC39620 | AKOS-22 | 878983-38-1 | - | |
AKOS-22 是一种有效的线粒体蛋白电压依赖性阴离子通道 1 (VDAC1) 抑制剂 (Kd=15.4 μM)。AKOS-22 与 VDAC1 相互作用,抑制 VDAC1 齐聚和凋亡。AKOS-22 对线粒体功能的保护作用。 | ||||
| GC39640 | GPLGIAGQ TFA | - | >99.50% / >98.00% | |
GPLGIAGQ TFA 是一种 MMP2 可切割的多肽,在脂质体和胶束纳米载体中都被用作刺激敏感的连接物,用于 MMP2 触发的肿瘤靶向治疗。GPLGIAGQ TFA可用于合成光动力治疗 (PDT) 中独特的 MMP2 靶向光敏剂。 | ||||
| GC39699 | Aurintricarboxylic acid | 4431-00-9 | - | |
A protein synthesis inhibitor with diverse biological activities | ||||
| GC39707 | Droloxifene | 82413-20-5 | >99.50% | |
A selective estrogen receptor modulator | ||||
| GC39708 | DT2216 | 2365172-42-3 | - | |
DT2216 是一种蛋白水解靶向嵌合体 (PROTAC),靶向 Bcl-xL 降解依赖于 Bcl-2 家族过表达蛋白(例如 Bcl-2、Bcl-xL 和 Mcl)的 T 细胞淋巴瘤-1.DT2216 抑制 G-68 细胞,IC50 值为 4.02 μM(72 小时)。 | ||||
| GC39719 | Nigericin | 28380-24-7 | >98.00% / >97.00% | |
A potassium ionophore | ||||
| GC39798 | Scoulerine | 6451-73-6 | >99.00% | |
A benzylisoquinoline alkaloid with diverse biological activities | ||||
| GC39808 | Didesmethylrocaglamide | 177262-30-5 | >98.00% | |
Didesmethylrocaglamide 是一种 Rocaglamide 的衍生物,也是一种有效的真核起始因子 4A (eIF4A) 抑制剂。Didesmethylrocaglamide 具有有效的生长抑制活性,IC50 为 5 nM。Didesmethylrocaglamide 抑制多种促进生长的信号通路,并诱导肿瘤细胞凋亡 (apoptosis)。抗肿瘤活性。 | ||||
| GC39814 | Mitoguazone | 459-86-9 | >98.00% | |
Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) 是一种具有有效抗肿瘤活性的合成多羰基衍生物。Mitoguazone 是一种可透过血脑屏障的竞争性的 S-腺苷-蛋氨酸脱羧酶 (S-adenosyl-methionine decarboxylase) 抑制剂,可破坏多胺的生物合成。Mitoguazone 诱导细胞凋亡 (apoptosis),可抑制 HIV DNA 整合到单核细胞和巨噬细胞中的细胞 DNA 中。Mitoguazone 具可用于急性白血病,霍奇金淋巴瘤和非霍奇金淋巴瘤的研究。 | ||||
| GC39815 | Semapimod tetrahydrochloride | 164301-51-3 | >98.00% | |
Semapimod tetrahydrochloride (CNI-1493) 是促炎细胞因子产生 (proinflammatory cytokine) 的抑制剂,可抑制TNF-α、IL-1β 和 IL-6。Semapimod tetrahydrochloride 抑制巨噬细胞 p38 MAPK 和一氧化氮生成。Semapimod tetrahydrochloride 抑制 TLR4 信号 (IC50≈0.3 μM)。Semapimod tetrahydrochloride 在多种炎症和自身免疫性疾病中具有潜在的作用。 | ||||
| GC39820 | Lometrexol hydrate | 1435784-14-7 | >99.00% | |
A GART inhibitor | ||||
| GC39827 | HM03 | 500565-15-1 | >99.50% | |
HM03 是一种有效的选择性的热休克 70 kDa 蛋白 5, HSPA5 (也称为 Bip,Grp78) 抑制剂,具有抗肿瘤活性。 | ||||
| GC40007 | Malformin A | 3022-92-2 | >95.00% | |
A cyclopentapeptide fungal metabolite with diverse biological activities | ||||
| GC40009 | Bostrycin | 21879-81-2 | >95.00% | |
An anthraquinone with diverse biological activities | ||||
| GC40022 | Roridin E | 16891-85-3 | >95.00% | |
A trichothecene mycotoxin | ||||
| GC40061 | Pestalotin | 34565-32-7 | >99.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC40065 | Meloxicam-d3 | 942047-63-4 | >99.00% | |
An internal standard for the quantification of meloxicam | ||||
| GC40067 | Herbimycin C | 91700-92-4 | >98.00% | |
A bacterial metabolite | ||||
| GC40076 | (-)-Voacangarine | 545-84-6 | >98.00% | |
A cytotoxic indole alkaloid | ||||
| GC40085 | Pazopanib-d6 | 1219592-01-4 | >99.00% | |
An internal standard for the quantification of pazopanib | ||||
| GC40094 | all-trans Retinoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of all-trans retinoic acid | ||||
| GC40116 | Aranorosin | 117184-53-9 | >95.00% | |
A fungal metabolite | ||||
| GC40118 | Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt) | - | >95.00% | |
An inhibitor of caspase-8 and granzyme B | ||||
| GC40119 | Z-YVADLD-FMK (trifluoroacetate salt) | - | >95.00% | |
A peptide | ||||
